Lexicon Pharmaceuticals (LXRX) Capital Expenditures Growth (5y) (2015 - 2023)
Powered by 
Analysis
Lexicon Pharmaceuticals (LXRX) Capital Expenditures Growth (5y) (2015 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Lexicon Pharmaceuticals | 978.15 Mn | 787.54 Mn | 653,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 94.26% |
| Jun 30, 2023 | 56.09% |
| Mar 31, 2023 | 44.04% |
| Dec 31, 2022 | 215.28% |
| Sep 30, 2022 | -42.01% |
| Mar 31, 2022 | -3.75% |
| Dec 31, 2021 | -31.09% |
| Sep 30, 2021 | 67.82% |
| Jun 30, 2021 | 135.77% |
| Mar 31, 2021 | -6.79% |
| Dec 31, 2020 | -26.16% |
| Sep 30, 2020 | -29.08% |
| Mar 31, 2019 | 20.11% |
| Dec 31, 2018 | -29.67% |
| Sep 30, 2018 | -59.28% |
| Jun 30, 2018 | -48.12% |
| Mar 31, 2018 | -45.59% |
| Dec 31, 2017 | -48.74% |
| Sep 30, 2017 | 4.06% |
| Jun 30, 2017 | -5.66% |